As described below, fibroblasts from 5 middle-aged fAD patients carrying PSEN1 mutations (herein fAD-PSEN1, age: 47.2 ± 10.2) were subsequently derived for validation experiments (Extended Data Table 1). This evidence concerns the gene PSEN1 and familial Alzheimer disease.